LCN2 and type 2 diabetes mellitus: Recent studies in human and animals have shown that both lipocalin-2 [9], [10], [11] and RBP4 [7], [12] are modulators of insulin signaling and their levels are elevated in subjects with obesity, insulin resistance, or type 2 diabetes.